Global Matrechs, Inc. Signs Manufacturing Agreement With Dow Corning
Tuesday September 5, 11:33 am ET
RIDGEFIELD, CT--(MARKET WIRE)--Sep 5, 2006 -- Global Matrechs, Inc. (OTC BB:GBMR.OB - News), a developer of advanced materials for nuclear and hazardous-waste containment and high-performance, nontoxic polyurethanes, announced today that it has signed a manufacturing agreement with Dow Corning Corporation, a global leader in supply of silicon-based products.
Dow Corning will manufacture NuCap(TM), Global Matrechs' lead product, an advanced silicone geo-polymer composite that provides superior containment of radioactive contaminants. Modifications to part of the facility at Dow Corning's manufacturing plant in Midland, MI that will manufacture NuCap(TM) will result in improvements in the manufacturing process efficiency. The upgrades are expected to expand Global Matrechs' ability to meet demand for its innovative materials.
Michael Sheppard, CEO of Global Matrechs, said, "This agreement is a very important advancement in the growth of this company. Dow Corning has collaborated with us for more than eighteen months to help us obtain the level of equipment, management, engineering support and training to meet the standards for quality and quantity required by the growing customer base for our NuCap(TM) materials. We believe this relationship with Dow Corning will enable us to successfully fill certain large orders anticipated in the near future."
About Dow Corning
Dow Corning (www.dowcorning.com) provides performance-enhancing solutions to serve the diverse needs of more than 25,000 customers worldwide. A global leader in silicon-based technology and innovation, offering more than 7,000 products and services, Dow Corning is equally owned by The Dow Chemical Company and Corning Incorporated. More than half of Dow Corning's sales are outside the United States.
About Global Matrechs
Global Matrechs (OTC BB:GBMR.OB - News) (www.globalmatrechs.com) operates a licensed technologies business. Through its licensed technologies business, Global Matrechs seeks to convert the licenses it has acquired in emerging technologies in the nuclear energy, environmental and chemical industries into manufactured products primarily through sub-licenses of those technologies to manufacturers.
Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "intend," and similar expressions. Such forward-looking statements, involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. The Company's future operating results are dependent upon many factors, including but not limited to the Company's ability to: (i) obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) build the management and human resources and infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company's control; and (iv) other risk factors discussed in the Company's periodic filings with the Securities and Exchange Commission, which are available for review at www.sec.gov under "Search for Company Filings."
Consulting For Strategic Growth1, Ltd. ("CFSG1") provides Global Matrechs with consulting, business advisory, investor relations, public relations and corporate development services. Independent of CFSG1's receipt of cash compensation from Global Matrechs, CFSG1 may choose to purchase the company's common stock and thereafter liquidate those securities at any time it deems appropriate to do so.